AQEMIA
Paris
About AQEMIA
AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates. The company utilizes advanced techniques, including generative AI and atomic scale physics, to design novel drugs tailored for specific therapeutic targets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $109.5M
- Funding stage: Early Stage Venture
- Last round: Grant (Apr 2025)
- Website: aqemia.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Machine Learning, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aqemia-98537 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.